Aimmune Therapeutics

Aimmune Therapeutics develops treatments to protect children with food allergies (peanut, milk, and egg) from the consequences of accidental exposure.



Post IPO Equity




Org chart

Andrew Oxtoby
President & CEO
Jim Pepin
SVP & General Counsel
Moreno Perugini
SVP, Global Medical Affairs
Doug Walker
SVP, IT & Facilities
Nicolas Fouché
SVP, Head of International
Jason Burdette
SVP & Head of Technical Operations
Louise Peacock
SVP, Head of Pharma R&D
Alicia Goodman
SVP, Human Resources
Paul Spence
SVP, U.S. Pharmaceuticals
Fabiana Lacerca-Allen
SVP, Compliance
Cathy Nolan
SVP, Strategy, Marketing & Innovation
Steve Killmeyer
VP, Head of Finance
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.